Endocrine Abstracts

Craniopharyngiomas are rare, benign tumors, typically found in childhood or early adulthood, that can cause a wide range of symptoms such as visual impairment, headaches, nausea and endocrine disturbances. Ewing sarcoma, on the other hand, is a rare and aggressive tumor that arise from primitive neuroectodermal cells and represents about 10% of all pediatric osseous primary tumors. We present the case of a 14-year-old patient who was admitted to our clinic in March 2022 for ob...

Background: Using new technologies, such as glucose sensors and insulin pumps, may help patients with type 1 diabetes mellitus achieve better glycemic control and quality of life. With the occasion of implementing the National Program for free distribution of continuous glucose monitoring systems (CGMS) starting with January 2019, children aged under 13 years were investigated in order to assess the association between previous use of CGMS and insulin pumps and the metabolic c...

Background: Type 1 diabetes is a chronic disease requiring constant management and a disciplined lifestyle, especially in children. Real-time continuous glucose monitoring system (RT-CGMS) can be a useful tool in maintaining good glycemic control. In our medical centre, beginning with January 2019, a National Program for free distribution of RT-CGMS has been set in motion. The results from one of our previous studies indicated a significant increase in glycosylated haemoglobin...

Introduction: Acromegaly is a rare endocrine disease characterised by excess GH produced by a pituitary adenoma. It is associated with several complications and comorbidities. Metabolic alterations such as diabetes and dyslipidemia are quite frequent described in these patients.Materials and methods: This is a retrospective observational cross-sectional study meant to assess the metabolic modifications in a group of acromegaly patients evaluated in our d...

Background: Real-Time Continuous Glucose Monitoring Systems (RT-CGMS) represent a minimally invasive method for frequent glucose monitoring, allowing a better glycemic control for patients with type 1 diabetes. With the occasion of implementing the National Program for free access to RT-CGMS, we assessed the 6 months impact of RT-CGMS on the metabolic control, evaluated by glycated haemoglobin (HbA1c).Methods: In this unicentric, prospective cohort study...